Buying Surgery Partners (SGRY)? Here's What You Must Know.

Shares of Surgery Partners have moved 0.5% today, and are now trading at a price of $41.3. Today's trading volume is 12,326 compared to the stock's average volume of 597,190.

Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. Based in Brentwood, United States the company has 9,100 full time employees and a market cap of $5,223,623,680.

The company is now trading -15.2% away from its average analyst target price of $48.7 per share. The 10 analysts following the stock have set target prices ranging from $39.0 to $65.0, and on average give Surgery Partners a rating of buy.

Over the last year, SGRY shares have gone up 45.7%, which represents a difference of 26.0% when compared to the S&P 500. The stock's 52 week high is $44.59 per share whereas its 52 week low is $20.46. With its gross margins declining a compounded average of -0.5% over the last 4 years, Surgery Partners may not have a strong enough business to maintain this trend.

Date Reported Revenue ($ k) Cost of Revenue ($ k) Gross Margins (%) YoY Growth (%)
2022-12-31 2,539,300 1,964,400 22.64 2.54
2021-12-31 2,225,100 1,733,700 22.08 8.13
2020-12-31 1,860,100 1,480,300 20.42 -11.75
2019-12-31 1,831,400 1,407,600 23.14 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS